test

Harold Schaaff

@Soleus Capital Management, L.p.

Latest period2024 - Q3ReportedManaged Assets$1.291BTotal holdings87
Assets growth rate13.9%Assets growth rate (2-Q avg)-0.97%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Soleus Capital Management, L.p.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 87 positions.

Assets under management

The assets under management (AUM) of Soleus Capital Management, L.p. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.291B in assets, with a quarterly growth rate of 13.9% and a 2-quarter average growth rate of -0.97%. The portfolio is managed by Harold Schaaff, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
XBISpdr Ser Tr
Recent Activity
New Position
6.89%
$88.92M↑ Call
900,000 shares@ $98.8 avg price
IOVAIovance Biotherapeutics Inc
Recent Activity
Increased 13%
6.21%
$80.083M
8.529M shares@ $9.39 avg price
TGTXTg Therapeutics Inc
Recent Activity
Decreased -30.47%
4.6%
$59.283M
2.535M shares@ $23.4 avg price
TERNTerns Pharmaceuticals Inc
Recent Activity
Increased 25.79%
4.02%
$51.904M
6.224M shares@ $8.35 avg price
AXGNAxogen Inc
Recent Activity
Decreased -9.07%
3.27%
$42.143M
3.006M shares@ $14.03 avg price
GRFSGrifols S A
Recent Activity
New Position
3.11%
$40.153M
4.522M shares@ $8.89 avg price
KRYSKrystal Biotech Inc
Recent Activity
Increased 72.21%
3.06%
$39.497M
216,979 shares@ $182.03 avg price
CCCCC4 Therapeutics Inc
Recent Activity
Increased 62.99%
2.92%
$37.643M
6.604M shares@ $5.7 avg price
UTHRUnited Therapeutics Corp Del
Recent Activity
Decreased -27.98%
2.83%
$36.514M
101,894 shares@ $358.36 avg price
SNYSanofi
Recent Activity
Increased 879.2%
2.74%
$35.27M
612,000 shares@ $57.63 avg price